Sanara MedTechSMTI +2.98%72 Gross Margin % is 93.08% as of Mar. 2026, which is 4% above its 10-year median of 89.68. GuruFocus rates SMTI with a GF Score™ of 72/100 and a GF Value™ of $45.54 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 806 Medical Devices & Instruments companies, Sanara MedTech ranks better than 97.52% on this metric.
The historical rank and industry rank for Sanara MedTech's Gross Margin % or its related term are showing as below:
SMTI'
s Gross Margin % Range Over the Past 10 Years
Min: 82.86 Med: 89.68 Max: 92.92
Current: 92.92
During the past 13 years, the highestGross Margin % of Sanara MedTech was 92.92%. The lowest was 82.86%. And the median was 89.68%.
SMTI's Gross Margin % is ranked better than 97.52% of 806
companies
in the Medical Devices & Instruments industry
Industry Median: 51.985
vs SMTI: 92.92
Sanara MedTech had a gross margin of 93.08% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Sanara MedTech was 0.60% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Sanara MedTech had a gross margin of 93.08% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Sanara MedTech Gross Margin % Related Terms
Sanara MedTech Gross Margin % Historical Data
* Premium members only.
The historical data trend for Sanara MedTech's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SMTI vs PDEX, UTMD, EMBC: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Sanara MedTech's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sanara MedTech Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sanara MedTech's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Sanara MedTech's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Sanara MedTech (SMTI) has a Gross Margin % of 93.08% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Sanara MedTech and its competitors. This is near median its historical median of 89.68. Over the past decade, Sanara MedTech's Gross Margin % has ranged from 82.86 to 92.92. According to the industry distribution chart, Sanara MedTech ranks #20 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 2.5%.
Is Sanara MedTech's Gross Margin % too high?
Sanara MedTech's current Gross Margin % of 93.08% is near median its 10-year median of 89.68. Over the past 10 years, this metric has ranged from a low of 82.86 to a high of 92.92. The Medical Devices & Instruments industry median Gross Margin % is 51.99. Sanara MedTech's value of 93.08% is 79.1% above this industry median. Based on the distribution chart, Sanara MedTech ranks #20 out of 806 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sanara MedTech has a GF Score™ of 72/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sanara MedTech's Gross Margin % compare to PDEX and UTMD?
According to the Medical Devices & Instruments industry distribution chart, Sanara MedTech ranks #20 out of 806 companies for Gross Margin %. This places Sanara MedTech in the top 3% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 51.99. Sanara MedTech's value of 93.08% is 79.1% above this benchmark. Historically, Sanara MedTech's own Gross Margin % has ranged from 82.86 to 92.92 over the past decade. While the company's 10-year median is 89.68 vs. the industry median of 51.99, Sanara MedTech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 51.99, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sanara MedTech's current Gross Margin % of 93.08% is 79.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Sanara MedTech and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 51.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sanara MedTech's current Gross Margin % is 93.08%, which is near median its own 10-year median of 89.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanara MedTech stock overvalued right now?
Based on GuruFocus' analysis, Sanara MedTech (SMTI) is currently considered Possible Value Trap. The stock's GF Value™ is $45.54, compared to a current price of $23.88 — trading 47.6% below its estimated fair value. The current Gross Margin % is 93.08%, which is near median its 10-year median of 89.68 and 79.1% above the Medical Devices & Instruments industry median of 51.99. Sanara MedTech's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Sanara MedTech (SMTI), the current Gross Margin % is 93.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sanara MedTech (SMTI) Overvalued in 2026?
Based on GuruFocus' analysis, Sanara MedTech stock appears to be undervalued.
The current stock price of $23.88 is trading 47.6% below its estimated GF Value™ of $45.54.
GuruFocus considers Sanara MedTech to be Possible Value Trap.
Key valuation signals for SMTI:
Gross Margin %: 93.08% (near median its 10-year median of 89.68)
GF Value™: $45.54 vs. price of $23.88 (47.6% below fair value)
Industry Position: 79.1% above the Medical Devices & Instruments median (#20 of 806)
No single metric tells the full story. See the SMTI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
72GF Score
Get the complete analysis for SMTI
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SMTI has been successfully added to your 
